The Department of Justice (DOJ) has launched a scathing lawsuit against CVS Health, accusing the pharmaceutical giant of fueling the opioid epidemic by knowingly filling unlawful prescriptions to meet corporate performance metrics. The civil complaint, unsealed Wednesday, alleges CVS facilitated the distribution of dangerous opioids, prioritizing profits over public safety.
According to the DOJ, CVS’s practices enabled the illegal proliferation of opioids by filling prescriptions that lacked legitimate medical purposes. The lawsuit covers activities from October 17, 2023, to the present and claims the company’s actions contributed significantly to the ongoing opioid crisis and related deaths.
Brian M. Boynton, head of the DOJ’s Civil Division, emphasized the gravity of the allegations. “The practices alleged contributed to the opioid crisis and opioid-related deaths, and today’s complaint seeks to hold CVS accountable for its misconduct,” he said.
The complaint claims CVS pharmacies were understaffed, leaving pharmacists vulnerable to fraudulent prescribers and so-called “pill mills.”
“This lawsuit alleges that CVS failed to exercise its critical role as gatekeeper of dangerous prescription opioids,” said U.S. Attorney Zachary A. Cunha for the District of Rhode Island, where the lawsuit originated. “When corporations such as CVS prize profits over patient safety and overburden their pharmacy staff… we will use every tool at our disposal to see that they answer for it.”
The DOJ’s allegations extend beyond the Controlled Substances Act, asserting CVS also violated the False Claims Act by seeking reimbursement from federal health care programs for illegitimate prescriptions.
Anne Milgram, Administrator of the Drug Enforcement Administration (DEA), did not mince words in her criticism of CVS’s practices.
“Simply put, they put profits over their obligation to keep their customers safe,” Milgram stated. “In the fight against the opioid epidemic, DEA will continue to be relentless in holding those accountable who violate our drug laws and place our communities in danger, whether they are a criminal cartel or a large pharmacy chain.”
CVS strongly denies the accusations, asserting that all prescriptions filled were lawful and compliant with government regulations.
“The government’s lawsuit seeks to impose a shifting standard for pharmacy practice,” a CVS spokesperson told The Hill. “Many of the litigation theories laid out in the complaint are not found in any statute or regulation and relate to topics on which the government has declined to provide guidance.”
The company added that the prescriptions in question were for FDA-approved opioid medications issued by licensed practitioners. CVS also highlighted its ongoing efforts to combat opioid misuse through innovative programs.
This is not the first time CVS has faced federal scrutiny over its handling of prescriptions. In 2011, the company paid a $17.5 million settlement for inflating prescription claims billed to Medicaid programs in multiple states. Earlier this month, House members launched an antitrust investigation into CVS Caremark, further intensifying federal scrutiny of the company’s practices.
The current lawsuit represents one of the most severe allegations against CVS, drawing attention to the company’s role in the broader opioid crisis that has devastated communities nationwide.
The opioid epidemic continues to claim tens of thousands of lives annually in the United States, driven in part by the overprescription and misuse of powerful painkillers. Pharmacies like CVS occupy a critical position as gatekeepers in the pharmaceutical distribution chain, responsible for ensuring that dangerous substances are dispensed appropriately.
Critics argue that corporate negligence and prioritization of profits over safety have exacerbated the crisis, and the DOJ’s lawsuit against CVS aims to hold the company accountable for its role.
The DOJ’s action against CVS sends a clear message to other pharmacy chains and health care providers: compliance with drug laws is not optional. The lawsuit underscores the need for systemic changes in how opioids are prescribed, dispensed, and monitored.
As the legal battle unfolds, the case against CVS may become a pivotal moment in the fight against the opioid epidemic, forcing both corporations and regulators to confront the devastating consequences of corporate misconduct.
For now, the accusations against CVS cast a harsh light on the pharmacy giant, raising questions about its commitment to safeguarding public health amidst a national crisis.
The post DOJ Sues CVS for Filling Unlawful Opioid Prescriptions appeared first on Daily News Cycle.
